India's Budget 2025-26 Coverage
Presented by:
spot_img

Topics: ALM223

Almirall S.A. Begins First Phase Clinical Study Of ALM223

Almirall S.A. (BME: ALM), a global pharmaceutical company focused on medical dermatology, today announced the initiation of the phase I study evaluating the safety,...

Trending

THE SNAPSHOTS

Sign up to get quick snaps of everyday happening, directly in your inbox.

We don’t spam! Read our privacy policy for more info.